Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
British Columbia Cancer Agency |
---|---|
Information provided by: | British Columbia Cancer Agency |
ClinicalTrials.gov Identifier: | NCT00798083 |
To investigate if topical amitriptyline 2%, ketamine 1%, and lidocaine 5% in pluronic lecitine organogel (AKL in PLO gel) can improve management of neuropathic pain from radiation skin reactions adjunctively or better than standard treatment.
Condition | Intervention | Phase |
---|---|---|
Neuropathic Pain Secondary to Radiation Therapy |
Drug: topical amitriptyline 2%, ketamine 1%, and lidocaine 5% in pluronic lecitine organogel(AKL in PLO gel) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Topical Amitriptyline, Ketamine and Lidocaine in Neuropathic Pain Caused by Radiation Skin Reaction: a Pilot Study |
Estimated Enrollment: | 22 |
Study Start Date: | April 2008 |
Estimated Study Completion Date: | April 2009 |
Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Isabella Uzaraga | 250 519 5500 | iuzaraga@bccancer.bc.ca |
Canada, British Columbia | |
BC Cancer Agency Vancouver Island BCCA | Recruiting |
Victoria, British Columbia, Canada, V8R 6V5 | |
Contact: Isabella Uzaraga 250 519 5500 iuzaraga2@bccancer.bc.ca |
Principal Investigator: | Isabella Uzaraga, MD | BC Cancer Agency - Vancouver Island Centre |
Responsible Party: | British Columbia Cancer Agency - Vancouver Island Centre ( Isabella Uzaraga ) |
Study ID Numbers: | BCCA001 |
Study First Received: | November 21, 2008 |
Last Updated: | November 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00798083 |
Health Authority: | Canada: Ethics Review Committee |
Excitatory Amino Acids Amitriptyline Ketamine |
Lidocaine Neoplasm Metastasis Pain |
Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Adrenergic Agents Molecular Mechanisms of Pharmacological Action Adrenergic Uptake Inhibitors Physiological Effects of Drugs Psychotropic Drugs Anesthetics Excitatory Amino Acid Agents Sensory System Agents Therapeutic Uses Analgesics Anti-Arrhythmia Agents |
Antidepressive Agents Excitatory Amino Acid Antagonists Anesthetics, Intravenous Central Nervous System Depressants Cardiovascular Agents Pharmacologic Actions Anesthetics, Dissociative Anesthetics, Local Antidepressive Agents, Tricyclic Analgesics, Non-Narcotic Anesthetics, General Peripheral Nervous System Agents Central Nervous System Agents |